» Articles » PMID: 16526022

Antitumor Action of Curcumin in Human Papillomavirus Associated Cells Involves Downregulation of Viral Oncogenes, Prevention of NFkB and AP-1 Translocation, and Modulation of Apoptosis

Overview
Journal Mol Carcinog
Date 2006 Mar 10
PMID 16526022
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumin (diferuloyl methane), the major yellow pigment from the rhizomes of turmeric (Curcuma longa Linn), has anticancer properties. Infection with high-risk human papillomaviruses (HPV) leads to development of cervical carcinoma, predominantly through the action of viral oncoproteins E6 and E7. The present study aims at analyzing the antitumor and antiviral properties of curcumin, on HPV associated cervical cancer cells. Our findings indicate curcumin to be cytotoxic to cervical cancer cells in a concentration-dependent and time-dependent manner. The cytotoxic activity was selectively more in HPV16 and HPV18 infected cells compared to non-HPV infected cells. Balance between tumor cell proliferation and spontaneous cell death via apoptosis had an important role in regulation of tumor cell growth. Curcumin-induced apoptosis in cervical cancer cells. Morphological hallmarks of apoptosis such as nuclear fragmentation and internucleosomal fragmentation of DNA were observed. Curcumin also selectively inhibited expression of viral oncogenes E6 and E7, evident from RT-PCR and Western blotting data. Electrophoretic mobility shift assay revealed that activation of NFkappaB-induced by TNFalpha is down regulated by curcumin. Curcumin blocked IkBalpha phosphorylation and degradation, leading to abrogation of NFkappaB activation. Curcumin also down regulated the expression of COX-2, a gene regulated by NFkappaB. Binding of AP-1, an indispensable component for efficient epithelial tissue-specific gene expression of HPV was also selectively down regulated by curcumin. These results provide attractive data for the possible use of curcumin in the management of HPV associated tumors.

Citing Articles

Recent advances in HPV biotechnology: understanding host-virus interactions and cancer progression - a review.

Yousaf S, Shehzadi A, Ahmad M, Asrar A, Ahmed I, Iqbal H Int J Surg. 2025; 110(12):8025-8036.

PMID: 39806745 PMC: 11634192. DOI: 10.1097/JS9.0000000000002117.


Current evidence and future direction on evaluating the anticancer effects of curcumin, gingerols, and shogaols in cervical cancer: A systematic review.

Abdull Rahim U, Mustapa M, Mohamed Shakrin N, Nurdin A, Mohamad Taridi N, Mohd Yusof Y PLoS One. 2024; 19(11):e0314280.

PMID: 39576841 PMC: 11584093. DOI: 10.1371/journal.pone.0314280.


Curcumin derivative C210 induces Epstein-Barr virus lytic cycle and inhibits virion production by disrupting Hsp90 function.

Chen L, Guo X, Lin W, Huang Y, Zhuang S, Li Q Sci Rep. 2024; 14(1):26694.

PMID: 39496752 PMC: 11535535. DOI: 10.1038/s41598-024-77294-w.


Physicochemical Characterization, Antioxidant, and Proliferative Activity of Colombian Propolis Extracts: A Comparative Study.

Buitrago D, Perdomo S, Silva F, Cely-Veloza W, Lafaurie G Molecules. 2024; 29(7).

PMID: 38611922 PMC: 11013913. DOI: 10.3390/molecules29071643.


Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021.

Duncan C, Gunosewoyo H, Mocerino M, Payne A Curr Med Chem. 2023; 31(33):5308-5350.

PMID: 37448363 DOI: 10.2174/0929867331666230713165407.